Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study

被引:0
|
作者
Sonoda, Dai [1 ]
Maruyama, Raito [1 ]
Kondo, Yasuto [1 ,2 ]
Naito, Masahito [1 ]
Mikubo, Masashi [1 ]
Shiomi, Kazu [1 ]
Satoh, Yukitoshi [1 ,2 ]
机构
[1] Kitasato Univ, Dept Thorac Surg, Sch Med, 1-15-1 Kitasato,Minami Ku, Sagamihara, Kanagawa 2520374, Japan
[2] Kitasato Univ, Dept Thorac Surg, Med Ctr, 6-100 Arai, Kitamoto, Saitama 36408501, Japan
关键词
Lung cancer; Older patients; Performance status; Prognostic factors; Recurrence; Treatment; ELDERLY-PATIENTS; LIFE EXPECTANCY; PHASE-III; OCTOGENARIANS;
D O I
10.1007/s00595-024-02938-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeSociety is aging, and the proportion of older patients with lung cancer is increasing. However, the treatment choices and prognoses for older patients with cancer recurrence remain unclear. We retrospectively investigated the treatment choices and prognoses of older patients with recurrence.MethodsWe conducted a retrospective review of 1100 patients who underwent complete resection for non-small cell lung cancer at Kitasato University Hospital between 2004 and 2017. Patients of >= 75 years of age were defined as older patients, and the prognosis and prognostic factors of these patients upon recurrence were examined.ResultsAmong the 290 patients who developed recurrence, 106 experienced recurrence at an older age. The factors associated with survival after recurrence included sex, time to recurrence, number of recurrences, performance status at recurrence, and active treatment. As the age at recurrence increased, the proportion of patients who did not receive active treatment increased, as did the proportion for whom the reason was the patient's and family's preferences.ConclusionsA considerable number of older patients who experience recurrence do not wish to receive active treatment. However, the prognosis can be improved by aggressive treatment for recurrence.
引用
收藏
页码:588 / 599
页数:12
相关论文
共 50 条
  • [41] Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer
    Thamrongjirapat, T.
    Muntham, D.
    Incharoen, P.
    Trachu, N.
    Sae-Lim, P.
    Sarachai, N.
    Khiewngam, K.
    Monnamo, N.
    Kantathut, N.
    Ngodngamthaweesuk, M.
    Ativitavas, T.
    Chansriwong, P.
    Nitiwarangkul, C.
    Ruangkanchanasetr, R.
    Kositwattanarerk, A.
    Sirachainan, E.
    Dejthevaporn, T.
    Reungwetwattana, T.
    BMC CANCER, 2024, 24 (01)
  • [42] Predicting Recurrence Using the Clinical Factors of Patients with Non-small Cell Lung Cancer After Curative Resection
    Lee, Hyun Joo
    Jo, Jisuk
    Son, Dae-Soon
    Lee, Jinseon
    Choi, Yong Soo
    Kim, Kwhanmien
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (05) : 824 - 830
  • [43] Patterns of treatment and survival among older patients with stage III non-small cell lung cancer
    Driessen, Elisabeth J. M.
    Schulkes, Karlijn J. G.
    Dingemans, Anne-Marie C.
    van Loon, Judith G. M.
    Hamaker, Marije E.
    Aarts, Mieke J.
    Janssen-Heijnen, Maryska L. G.
    LUNG CANCER, 2018, 116 : 55 - 61
  • [44] Prognostic factors in non-small cell lung carcinoma
    Koutsami, MK
    Gorgoulis, VG
    Kastrinakis, NG
    Asimacopoulos, PJ
    Kittas, C
    ANTICANCER RESEARCH, 2002, 22 (1A) : 347 - 374
  • [45] Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer
    Sonoda, Dai
    Kondo, Yasuto
    Maruyama, Raito
    Naito, Masahito
    Mikubo, Masashi
    Shiomi, Kazu
    Satoh, Yukitoshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2024, : 352 - 361
  • [46] Analysis of Prognostic Factors According to Performance Status in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Adachi, Y.
    Tamiya, A.
    Taniguchi, Y.
    Enomoto, T.
    Azuma, K.
    Kouno, S.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S663 - S663
  • [47] Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection
    Ramos Antuna, Aida
    Alvarez Vega, Marco
    Rodriguez Sanchez, Carmen
    Martin Fernandez, Vanesa
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2018, 79 (02) : 101 - 107
  • [48] Survival and Treatment Pattern of Non-small Cell Lung Cancer Over 20 Years
    Pitz, Marshall W.
    Musto, Grace
    Demers, Alain A.
    Kliewer, Erich V.
    Navaratnam, Srisala
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 492 - 498
  • [49] Post-Recurrence Survival Analysis of Stage I Non-Small Cell Lung Cancer: Prognostic Significance of Local Treatment
    Lee, Kanghoon
    Kim, Hyeong Ryul
    Kim, Dong Kwan
    Kim, Yong-Hee
    Park, Seung-Il
    Choi, Se Hoon
    Hwang, Su Kyung
    Bok, Jin San
    Lee, Han Pil
    Chong, Byung Kwon
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S687 - S688
  • [50] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396